000			02057 a2200565 4500
005			20250516173324.0
264		0	_c20140828
008			201408s 0 0 eng d
022			_a1476-5381
024	7		_a10.1111/bph.12406 _2doi
040			_aNLM _beng _cNLM
100	1		_aYadav, Vivek R
245	0	0	_aPreclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. _h[electronic resource]
260			_bBritish journal of pharmacology _cDec 2013
300			_a1436-48 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdenocarcinoma of Lung
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aApoptosis Regulatory Proteins _xmetabolism
650	0	4	_aBenzylidene Compounds _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFluorodeoxyglucose F18
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aKi-67 Antigen _xmetabolism
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMultimodal Imaging
650	0	4	_aPhosphorylation
650	0	4	_aPiperidones _xpharmacology
650	0	4	_aPositron-Emission Tomography
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aTranscription Factor RelA _xgenetics
650	0	4	_aTransfection
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aSahoo, Kaustuv
700	1		_aAwasthi, Vibhudutta
773	0		_tBritish journal of pharmacology _gvol. 170 _gno. 7 _gp. 1436-48
856	4	0	_uhttps://doi.org/10.1111/bph.12406 _zAvailable from publisher's website
999			_c23148965 _d23148965